Starton Therapeutics Signs Trial Agreement With Stanford Medicine
The agreement covers an investigator-initiated trial evaluating STAR-LLD with a novel CAR-T therapy for multiple myeloma.
Related stories
Teck Resources Publishes Q3 2026 Earnings Call Transcript
M impact | EQUITY | Oct 29, 2026, 11:59 PM UTC
Aecon Group Reports Quarterly Results Through September 30
Aecon Group reported results for the quarter ended September 30. Figures are in Canadian dollars unless otherwise stated.
M impact | EQUITY | Oct 29, 2026, 11:58 PM UTC
Eastman Chemical Reports Quarterly Results Through September 30
The LSEG-generated earnings summary covers Eastman Chemical Co.'s quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 11:58 PM UTC
Coles Shares Fall 12% After Sales Disappoint, Fuel Costs Threaten Profits
Coles said supermarket same-store sales rose 2.7% in the 13 weeks through Sept. 27 and warned that rising fuel costs would hurt profits. Its shares fell 12%, putting them on course
M impact | EQUITY | Oct 29, 2026, 11:57 PM UTC
TFS Financial Reports Quarterly Results
TFS Financial Corp reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC
FirstCash Shares Decline 14.75% as Law Firm Investigates Potential Securities Fraud
The Law Offices of Frank R. Cruz says it continues investigating potential securities fraud after a 14.75% decline in FirstCash Holdings shares.
M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC